Mark Faupel
Fortuna: 1 M $ al 31/07/2026
Fortuna: 1 M $ al 31/07/2026
Mark L.
Faupel is the founder of Guided Therapeutics, Inc., founded in 1992, serving as President, CEO, CFO, COO & Director.
Dr. Faupel is also the founder of MacKay Life Sciences, Inc...
Dr. Faupel is currently a Member at Shenghuo Medical LLC.
Formerly, Dr. Faupel was a Member at the European School of Oncology.
Dr. Faupel earned a doctorate from the University of Georgia.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 18/03/2025 | 4.824.361 ( 5 % ) | 1 M $ | 31/07/2026 | |
| 18/03/2025 | 97 ( 18,65 % ) | 29 $ | 31/07/2026 | |
| 18/03/2025 | 38 ( 8,68 % ) | 11 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GUIDED THERAPEUTICS, INC. | Director Ejecutivo | 06/03/2023 |
Shenghuo Medical LLC | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
MacKay Life Sciences, Inc.
MacKay Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops medical device and associated diagnostic systems to assist in detecting breast cancer | Fundador | 01/01/1998 |
European School of Oncology | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
MacKay Life Sciences, Inc.
MacKay Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops medical device and associated diagnostic systems to assist in detecting breast cancer | Health Technology |
Guided Therapeutics, Inc.
Guided Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical diagnostic products | Health Technology |
European School of Oncology | |
University of Georgia
University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenghuo Medical LLC |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.